P. Karamanakos

发表

Acute-phase response to benzo[a]pyrene and induction of rat ALDH3A1.

M. Marselos, P. Pappas, M. Sotiropoulou, 2003, Chemico-biological interactions.

Comment on "Disulfiram-like effect of cyproterone acetate" [Z. Nitzan, M. Dan, Eur. J. Obstet. Gynecol. Reprod. Biol.].

M. Marselos, P. Pappas, P. Karamanakos, 2009, European journal of obstetrics, gynecology, and reproductive biology.

Comment on “Dextromethorphan-induced serotonin syndrome”

P. Karamanakos, E. Panteli, 2008, Clinical toxicology.

Possible role for furazolidone in the treatment of glioblastoma multiforme.

P. Karamanakos, 2013, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Malignant giant cell tumor in the posterior fossa of a neonate.

R. Vanninen, I. Alafuzoff, E. Pirinen, 2010, Journal of neurosurgery. Pediatrics.

Phenobarbital inducibility and differences in protein expression of an animal model.

V. Vasiliou, M. Marselos, P. Pappas, 2001, Chemico-biological interactions.

Ontogenesis and expression of ALDH activity in the skin and the eye of the rat.

V. Vasiliou, M. Marselos, P. Pappas, 1997, Advances in experimental medicine and biology.

CYP2E1 and risk of chemically mediated cancers

D. Trafalis, P. Karamanakos, C. Tsigris, 2010, Expert opinion on drug metabolism & toxicology.

Inhibition of rat hepatic CYP2E1 by quinacrine: molecular modeling investigation and effects on 4-(methyl nitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced mutagenicity

M. Marselos, M. Konstandi, D. Trafalis, 2009, Archives of Toxicology.

Mutagenicity, developmental toxicity and carcinogenicity of cannabis

M. Marselos, P. Karamanakos, 1999, Addiction biology.

Increased Brain Serotonin Rather Than Increased Blood Acetaldehyde as a Common Denominator Behind Alleged Disulfiram-Like Reactions

M. Marselos, P. Pappas, P. Karamanakos, 2020, International journal of toxicology.

The Alcohol Intolerance Produced by Isoniazid Is Not Due to a Disulfiram-Like Reaction Despite Aldehyde Dehydrogenase Inhibition

M. Marselos, P. Pappas, P. Karamanakos, 2016, Pharmacology.

Disulfiram neuropathy: two cases of distal axonopathy

M. Marselos, P. Pappas, P. Karamanakos, 2008, Clinical toxicology.

A randomized outcome study of enteral versus intravenous nimodipine in 171 patients after acute aneurysmal subarachnoid hemorrhage.

R. Vanninen, J. Rinne, M. Kurki, 2012, World neurosurgery.

Involvement of the brain serotonergic system in the locomotor stimulant effects of chlorpheniramine in Wistar rats: implication of postsynaptic 5-HT1A receptors

M. Marselos, P. Pappas, P. Karamanakos, 2004, Behavioural Brain Research.

Comment on: Sensory-motor axonal polyneuropathy involving cranial nerves: An uncommon manifestation of disulfiram toxicity (Santos et al., Clin Neurol Neurosurg, 152:12–15, 2016)

P. Karamanakos, E. Panteli, 2017, Clinical Neurology and Neurosurgery.

Differentiation of disulfiram effects on central catecholamines and hepatic ethanol metabolism.

M. Marselos, P. Pappas, P. Karamanakos, 2001, Pharmacology & toxicology.

Risk factors for three phases of 12-month mortality in 1657 patients from a defined population after acute aneurysmal subarachnoid hemorrhage.

Mikael von und zu Fraunberg, Timo Koivisto, Juha Hernesniemi, 2012, World neurosurgery.

Comment on: Disulfiram Induced Psychosis (Mohapatra and Rath, Clin Psychopharmacol Neurosci 2017;15:68-69)

P. Karamanakos, E. Panteli, 2017, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Comment on: “Disulfiram-induced De novo Convulsions Without Alcohol Challenge: Case Series and Review of Literature” (Kulkarni and Bairy, Indian J Psychol Med, Jul-Sep; 37(3): 345-8, 2015)

M. Marselos, P. Karamanakos, 2016, Indian journal of psychological medicine.

Chronic subdural haematoma after endoscopic treatment of a supracellar arachnoid cyst.

A. Ronkainen, P. Karamanakos, T. Koivisto, 2009, Acta neurologica Belgica.

Evidence for the efficacy of disulfiram and copper combination in glioblastoma multiforme - A propos of a case.

D. Kardamakis, M. Marselos, G. Nasioulas, 2017, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Furazolidone and Serotonin Syndrome: Is there any Association?

P. Karamanakos, 2008, Clinics.

Pharmaceutical Agents Known to Produce Disulfiram-Like Reaction: Effects on Hepatic Ethanol Metabolism and Brain Monoamines

Christoforos Thomas, M. Marselos, P. Pappas, 2007, International journal of toxicology.

Comment on: Chlorpheniramine exerts anxiolytic-like effects and activates prefrontal 5-HT systems in mice (Miyata S. et al., Psychopharmacology, 2009)

P. Karamanakos, 2011, Psychopharmacology.

The impact of endovascular management on the outcome of aneurysmal subarachnoid hemorrhage in the elderly in Eastern Finland

R. Vanninen, J. Rinne, H. Manninen, 2010, Acta Neurochirurgica.

The possibility of serotonin syndrome brought about by the use of metronidazole.

P. Karamanakos, 2008, Minerva Anestesiologica.

Role of Serotonin in MODS: Deficiency of Serotonin Protects Against Zymosan-Induced Multiple Organ Failure in Mice.

P. Karamanakos, D. Aretha, F. Fligou, 2015, Shock.

Optimal treatment of a recurrent giant craniopharyngioma: lessons from a case.

N. Papadakis, P. Karamanakos, K. Liaropoulos, 2008, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Early surgical results on acute arterial occlusion of the extremities.

P. Karamanakos, P. Balas, G. Bonatsos, 1985, The Journal of cardiovascular surgery.

Abrupt Discontinuation Versus Down-Titration of Vasopressin in Patients Recovering from Septic Shock.

P. Kiekkas, P. Karamanakos, D. Aretha, 2021, Shock.